Utilizing software updates for the glycocheck analysis allowing automated real-time evaluation of the glycocalyx and future development of a point-of-care assays for syndecan would provide clinically useful bedside tools for assessment of microvascular damage and plasma leakage in dengue patients. The gene discussed is SDC1; the disease is dengue disease.